blogs created to prevent or detect a crime

This blog is brougt to you consistent with subsection 3 of the Protection from Harassment Act - i.e. blogs created to prevent or detect a crime

Saturday, 30 June 2012

Steve Green CCHR N Z presents award to Maria Bradshaw - both are co-founders of CASPER

CCHR NZ Event featuring special guest from CASPER - 23 June 2012 (4 photos)

Steve Green reads out the international Human Rights award that Maria Bradshaw received in Los Angeles in Feb 2012!/photo.php?fbid=386308721428415&set=a.386308564761764.85865.102661973126426&type=1&theater

Maria Bradshaw bought by CCHR Scientology - just like FIDDAMAN

CCHR 2012 Human Rights Awards—Slide Show


CCHR International

Here's a slide show of our Human Rights Awards banquet featuring CCHR Commissioners, Actors Danny Masterson, Ethan Suplee, Jenna Elfman, Marisol Nichols and Nancy Cartwright, and this year's award winners, Detroit Mother Maryanne Godboldo, Psychology Instructor Lisa Cain, Child Advocate Maria Bradshaw and Chill EB. Click here to watch the Maryanne Godboldo human rights award video, presented by Ethan Suplee & Danny Masterson

— with Marisol Nichols, Nancy Cartwright, Danny Masterson and JENNA ELFMAN at The Westin Bonaventure Hotel & Suites.


Friday, 29 June 2012

@ GSK PAXIL SEROXAT withdrawal payout was $5600 = £3500 ...don't let FIDDAMAN fool you !

 ...they called me and just took my story over the phone. I hoped that it would make a difference, but figured I'd never hear from them again. I can't remember how much later it was, but I got a check in the mail for $5600!!! I suppose that I'm not suppose to talk about that, but I don't give a flying f who knows it. .....

Wednesday, 27 June 2012

SSRI FIDDAMAN blog - Jury rejects insanity in Zoloft rape case; ex-cop will go to jail

A San Bernardino County jury Tuesday rejected a former Westminster police detective’s defense that he was legally insane due to antidepressant use when he kidnapped and brutally raped a waitress from the Ontario Mills Mall two years ago.

The decision in the sanity phase of the trial means Anthony Orban will serve time in jail rather than receive treatment at a state mental hospital.

Deputy Dist. Atty. Debbie Ploghaus said Tuesday she was very happy with the verdict and considered the Zoloft defense to be a ruse concocted after Orban was arrested. "He's very dangerous. He's very manipulative," she said. "I truly believe in my heart that he had no intention of letting her go."

Orban testified that he had no memory of the lengthy attack and blamed a psychotic break induced by a powerful dose of the popular antidepressant Zoloft, which he also blamed for triggering hallucinations and suicidal and homicidal fantasies during the week of the abduction.

The same jury earlier this month found Orban guilty of kidnapping, rape and multiple counts of sexual assault, dismissing the defense’s claims that Zoloft had rendered Orban mentally “unconscious” and therefore not responsible for his actions.

Zoloft again was central to the defense in the sanity phase, when Orban’s attorney, James Blatt, tried to convince the jury that his client should be sent to a state mental hospital for treatment, not prison.

Defense witness Dr. Peter Breggin, a New York psychiatrist who has testified about the dangers of psychotropic drugs in trials across North America, told jurors that Orban was “zombie-like” in the days leading up to the attack. He said that Orban had stopped taking the prescribed antidepressant, then resumed it at full dose, provoking a psychotic break during which he was "delirious" and not fully aware of his actions.

The main witness for the prosecution, clinical psychologist Dr. Craig Rath of San Bernardino, on Thursday told the jury that Orban’s blackout was caused more by alcohol than by Zoloft. The day of the attack, Orban and a friend barhopped across Ontario, ordering eight margaritas and two pitchers of beer between them, according to evidence presented at the trial.

"He was not insane," said Roth, testifying about his court-ordered analysis of Orban’s mental state. "He understood the nature and quality of his acts and could distinguish between right and wrong."

During the trial, Ploghaus called the so-called Zoloft defense a "bunch of baloney," saying that Orban had "sex on his mind" shortly before the attack. The night before, he had an argument with his wife and, in the hours before the abduction, sent 45 text messages to a woman with whom he'd recently had an affair.

The victim, a 25-year-old waitress, testified earlier in the trial that Orban kidnapped her as she walked to her car in the Ontario Mills Mall parking lot, then forced her to drive north to Fontana. After they stopped at a self-storage lot, Orban brutally raped and tormented her, she said.

When Orban was distracted by an incoming cellphone call, the woman said, she jumped out of the car and ran to safety at a nearby liquor store. Police later recovered Orban's gun, with his name on it, from the victim's car

Japan introduction of PAXIL / Seroxat 1999 - linked to documented reduction of suicide - goodnews FIDDAMAN CASPER?

extract -

The number of suicides in Japan each year -- which hit a peak of 33,048 in 1999 -- declined 3.3% in 2000 and another 2.9% in 2001, the first full two years that SSRIs were available. However, the rate remains very high compared with earlier years, and many factors can contribute to suicide, so it's too early to tell whether the new drugs contributed to the reduction.

A newspaper ad by Japanese drug maker Shionogi & Co. promoting awareness of depression. It shows actress Nana Kinomi urging people to talk about the disease.

Japanese sales of GlaxoSmithKline's Paxil reached ¥12 billion ($96.5 million) in 2001, its first full year on the market, and the figure is on track to rise this year. By comparison, U.S. sales of the drug last year were $1.8 billion. Japanese sales of Luvox and Depromel -- the name under which the drug is sold by Meiji's marketing partner, Fujisawa -- totaled ¥14.5 billion last year. (In May Solvay removed Luvox from the U.S. market, where it had been approved to treat obsessive-compulsive disorder, after the Food and Drug Administration cited problems with documents filed by Solvay to the FDA. The company, which has been the drug's U.S. marketer, says Luvox is safe and expects it to be back on the market next year. The generic form of the drug, fluvoxamine, is still sold in the U.S.)

Other drug companies have also ramped up their efforts in Japan. Pfizer Inc. had started trials of its blockbuster Zoloft in Japan in the early '90s, but its crucial large-scale human trial failed to use strict enough standards when picking patients, says Kenneth Wolski, who oversaw the trial as head of development for Pfizer's Japan subsidiary until he left the company in 1996. The company's new-drug application, which has been pending with Japanese regulators since 1998, hasn't been approved. A Pfizer spokesman blamed the low awareness of depression in Japan at the time, and "different standards in clinical-trial design." Two months ago, Pfizer announced a new clinical trial of Zoloft at 20 sites across Japan.

And Prozac -- which had world-wide sales of $1.99 billion and U.S. sales of $1.53 billion last year -- is finally coming to Japan. Andrew Macarenas, head of Lilly's Japan operations, says it should be on the market by 2004 -- some 17 years after it first went on sale in the U.S. The company is preparing the way by paying for the activities of a committee of Japanese doctors that promotes awareness of depression. The committee holds seminars for doctors and operates a Web site. "A number of things are happening to take mental health out of the cupboard" in Japan, says Mr. Macarenas. "It's not a taboo anymore."

The message from drug companies has fit well with Japan's medical culture. Japanese doctors are accustomed to loading up patients with medication, and are permitted to sell drugs directly to patients, often at a significant profit. Meiji and Glaxo have conducted hundreds of seminars about depression for general practitioners and psychiatrists across Japan, and the companies say interest is strong.

Tuesday, 26 June 2012

Antidepressants Market Share by prescription 2008 - Paxil Seroxat became irrelevant like FIDDAMAN

GSK - in no great rush to release Paxil CR (Seroxat) Japan - more FIDDAMAN bullshit revealed

Dainippon Sum.Pharma : Anti-depressant Paxil CR Tablets newly launched


June 22, 2012

Anti-depressant Paxil® CR Tablets newly launched

GlaxoSmithKline K.K. Dainippon Sumitomo Pharma Co., Ltd.

GlaxoSmithKline K.K. (President: Philippe Fauchet, Head Office: Shibuya-ku, Tokyo, hereinafter referred to as GSK) announces that it has launched its anti-depressant Paxil® CR Tablets 12.5mg and Paxil® CR Tablets 25mg (paroxetine hydrochloride hydrate, hereinafter referred to as Paxil® CR Tablets, CR stands for Controlled Release) in Japan on June 22, following its NHI price listing on the same day.

GSK and Dainippon Sumitomo Pharma Co., Ltd. (President: Masayo Tada, Head Office: Chuo-ku, Osaka, hereinafter referred to as DSP) have started co-promoting Paxil® CR Tablets from April 1, 2012.

Paxil® CR tablets is the controlled-release1 formulation of Paxil® tablets, an SSRI (selective serotonin reuptake inhibitor) anti-depressant. It received regulatory approval in Japan from MHLW on 18 January 2012 for the indication of depression and depressive state. Overseas, development of anti-depressants using new formulation technology are being conducted actively and with the approval of Paxil® CR Tablets, Japan too has entered the era of controlled-release formulations. Paxil® CR Tablets was approved in the US in 1999 and as of June 2011, has been approved and widely used in over 40 countries worldwide.

Sunday, 24 June 2012

GSK - SEROXAT Litigation massive payout - see Bob FIDDAMAN blog for details

A class action settlement has been reached in a class action lawsuit against GlaxoSmithKline LLC (“GSK” or “GlaxoSmithKline”) pending in the Superior Court for the State of California County of Los Angeles (styled Grair v. GlaxoSmithKline, Class Action Case No. BC 288536), alleging, among other things, that GlaxoSmithKline employed false and deceptive marketing by misrepresentations and failing to disclose material information to the class and healthcare providers that the prescription antidepressant medication Paxil, an FDA-approved prescription medication commonly used to treat depression, obsessive-compulsive disorder, generalized anxiety disorder, social anxiety disorder, and post-traumatic stress disorder, was habit forming or addictive and about Paxil’s risks and unique frequency and severity of symptoms on withdrawal or discontinuation of Paxil, according to the California Paxil Antidepressant class action settlement notice.

Class Members in the California Paxil Antidepressant settlement reportedly include the following persons, unless otherwise excluded:

All natural persons who: (1) commenced a Paxil prescription between January 14, 1999 and January 1, 2003; (2) were 18 years old or older at the time they commenced their prescription; and (3) were residents of the State of California at the time they commenced their prescription.

The Paxil Antidepressant settlement reportedly provides monetary compensation as follows:

GlaxoSmithKline shall pay up to a total of eight million five hundred thousand dollars ($8,500,000.00) to provide a full refund of the Out-of-Pocket Expenses of Settlement Class Members who timely submit a valid Proof of Purchase and a sworn statement verifying eligibility. In the event the total amount of valid claims submitted by Settlement Class Members with valid Proof of Purchase exceeds $8,500,000.00, then the payment to those Class Members will be reduced pro rata so that a total of not more than $8,500,000.00 will be paid to Settlement Class Members with valid Proof of Purchase. GlaxoSmithKline shall reimburse Out-of-Pocket Expenses incurred by Settlement Class Members who timely submit a sworn statement verifying eligibility but who do not have valid Proof of Purchase up to eighty dollars ($80.00) per claimant. In the event the total amount of valid claims submitted by Settlement Class Members who do not have valid Proof of Purchase exceeds five hundred thousand dollars ($500,000.00), then the payment to those Class Members will be reduced pro rata so that a total of not more than $500,000.00 will be paid to Settlement Class Members who do not have valid Proof of Purchase.

Under the California Paxil Antidepressant Class Action Settlement, only Out-of-Pocket Expenses, including copayments and deductibles, you incurred for Paxil from January 1, 1999 through January 1, 2003 will qualify.

The Paxil Antidepressant settlement also provides that GlaxoSmithKline shall include certain information about Paxil ® or Paxil CR® on its corporate website as long as Paxil® or Paxil CR® is listed as a GlaxoSmithKline product on that website and that should GlaxoSmithKline in the future market or sell Paxil® or Paxil CR® or generic paroxetine in the United States, then GlaxoSmithKline will not advertise the product as non-habit forming and will comply with all FDA requirements.

The Court will hold a Fairness Hearing at 9:00 a.m. on November 13, 2012 at Department 323 of the Superior Court for the State of California County of Los Angeles located at Central Civil West Courthouse, 600 S Commonwealth Ave., Los Angeles, CA 90005 to consider whether the Paxil Antidepressant settlement is fair, reasonable, and adequate and will decide whether to approve the settlement and the motion for attorneys’ fees, expenses, and awards to the Class Representatives.

For more information about the proposed Paxil Antidepressant class action settlement, visit the California Paxil Antidepressant settlement website:

Saturday, 23 June 2012

Maria Bradshaw protests against Dr David Healy's favourite treatment ECT - thats some campaign your in FIDDAMAN !!

Margaret, Steve, Maria, Terata, Monte, Dana and Rita.

Recently the CCHR team visited Napier to attend the 6th National Electro Convulsive Therapy (ECT) Conference sponsored by drug company Eli Lilly.

In an unprecedented move, Steve managed to get CCHR into the conference due to the amount of work that CCHR had done working with victims of Electroshock.

Steve, Maria and Margaret sat in the front row of the conference, along with about 50 psychiatrists and other medical and psychiatric staff. Outside, the rest of the team approached the attendees in the break periods, handed out DVDs and conducted video interviews on those that were brave enough to take part and share their points of view.

The first speaker was the Ministry of Health (MoH) who explained that he had worked for the past decade with the Director of Mental Health and 8 of those years on two petitions against ECT from Patients Rights Advocacy Waikato (PRAW) and CCHR NZ!

A forensic consultant psychiatrist then spoke about the Lake Alice atrocities, including the psychiatrist in charge of the Child and Adolescent Unit, Selwyn Leeks. Again, this is CCHR's work, being the NGO that uncovered the abuses in the 1970s and assisted the child-victims through to present day! The presenter surmised that if the NZ Government

had investigated, apologised and paid out millions of dollars in compensation, that he believed the abuse did happen and that it is part of their (psychiatry's) history.

After going through a timeline of what happened at Lake Alice and some of the things overseas he told the audience that this is their history that they had to front up to it and even mentioned that psychiatry was an agent of social control. He came to the point in his slide that showed CCHR NZ's submission to the United Nations this year and asked if anyone had heard of them (to which Steve put his hand up announcing that he is from CCHR).

Margaret is an ECT survivor and had received the destructive treatment during her teenage years. Sadly her story is shared by many. CCHR NZ had acknowledged all the work she did a few years ago in bringing about awareness of ECT (including 3,000 petition signatures in 3 weeks). With extreme courage she asked the conference organiser if she could speak at the conference and then delivered a powerful 10 minute speech on why she thought the practice was barbaric and should be banned. This was in front of the key psychiatrists who administer ECT from around the country!

Amusingly too, the next item was a documentary on ECT (TV3 60 Minutes) and who should you see on the large screen but Margaret herself campaigning against ECT. We are very proud of you Margaret, well done!

On completion of the conference, Steve (kindly) offered all attendees an impactful 3 minute video on ECT and CCHR documentaries as a thank you for allowing CCHR NZ to attend the conference. The conference organiser announced this and each attendee (mostly psychiatrists) got copies of CCHR's "Making a Killing", "Marketing of Madness", and "Industry of Death" DVDs.

This has helped put CCHR NZ front and centre for victims of psychiatric abuse with the shock doctors and the MoH.

An amazingly productive effort by a team willing to get in there and help - THANK YOU!

Toran Henry death - manslaughter? ............what ever happened to that claim FIDDAMAN?

POLICE REVIEWING MANSLAUGHTER CHARGES FOLLOWING YOUTH SUICIDEPosted by: Clare Swinney ⋅ November 5, 2008 ⋅ Post a comment

Tags: Add new tag, Bradshaw, CCHR, Police, psychiatry Posted in: Health, News

From the Citizens Commission on Human Rights

November 4th 2008

Auckland mother Maria Bradshaw revealed that the Police will be referring the case of the death of her son, Toran Henry, to Crown Law for possible manslaughter charges.

In a moving speech at the Citizens Commission on Human Rights exhibition opening at the ASB Showgrounds on the weekend, Ms Bradshaw said it was, “a small win in a hard battle to bring out the truth of Toran’s death.” Ms Bradshaw has fought with mental health officials since her 17-year-old son took his life while he was on antidepressants in March this year. Ms Bradshaw claims the level of care for her son was negligent and irresponsible and that he never should have been prescribed antidepressants at such a young age. She also claims the psychiatric doctor stated Toran would be able cease taking the drugs to drink alcohol on the weekends and resume taking them afterwards.

In her talk that was given at the opening of an exhibition displaying the horrors of psychiatric abuse she said her son had been upset at the break-up with his girlfriend and that he fell victim to the psychiatric system of drugging people for ordinary life problems. She claimed she was threatened to have her son taken off her if she did not go along with the antidepressant treatment, which she opposed.

The Police referral to have Crown Law examine the case for possible manslaughter charges comes on the heels of a damning yet-to-be-published external report into the mental health care surrounding Toran Henry’s death.

Citizens Commission on Human Rights director, Mr Steve Green cited another case where the United Kingdom Police levelled manslaughter charges against a psychiatrist, Dr Peter Fisher, the NZ psychiatrist who was involved in three deaths including the case where psychiatric patient, Mark Burton broke into his mother’s home and stabbed her to death the day after Fisher had discharged him. Dr Fisher moved to England, where he practiced illegally. UK police became involved due to negligence over the suicide of one of his patients who overdosed on painkillers.

“Serious adverse events from psychotropic drugs such as antidepressants are well known by doctors. International warnings have been published around suicide in under-18-year olds, including New Zealand’s own Medsafe,” Mr Green said.

Mr Green believes strong measures need to be taken to prevent future deaths by suicide by people on psychotropic medication. The United States has now recorded that half of their suicides are committed by people on antidepressants, a worrying trend he doesn’t want in New Zealand.


Maria Bradshaw, mother of 17-year-old Toran Henry leant her weight behind the psychiatric labelling and drugging campaign, by travelling to Auckland especially to be a guest speaker. Amongst other things, she spoke out against the complete lack of objective medical tests in mental health, which ended with her son being prescribed an antidepressant and taking his own life earlier this year.

CCHR’s director, Mr Steve Green says the psychiatric abuse of human rights is worst when it is directed at kids, such as the Children of Lake Alice, which the Commission exposed in the mid 1970s. Current day psychiatric abuse of children are the powerful methamphetamine-based stimulants, anti-psychotics and anti-depressants administered for conditions such as Attention Deficit Hyperactivity Disorder (ADHD), which he says was literally voted into existence.

“In this country the use of anti-depressants for teenagers is very controversial with claims of how they cause suicidal behaviour,” he said. The Ministry of Health has issued advice to doctors and is requiring warnings on all antidepressants to indicate possible increased suicide risk and the need to closely monitor patients with depression, particularly young persons.

The Commission is now working on cases where young people have committed suicide while in mental health care and assisting families through the complaint processes. Suicide is a big issue; according to the Chief Coroner, 511 suicides were reported in the year ended in June, surpassing road deaths.

“One is too many, these are devastating events that are generally ignored, until it happens to your family or a close friend, when it is too late. This is why the Commission is now working on this level and holding public exhibitions, to help educate people – information empowers people and this is vital,” Mr Green said.

“The display highlights the absolute need to reform key areas of mental health treatment,” Green says and he cites the continued use of electric shock as well as the many abuses that have occurred within New Zealand psychiatry, like electric shocking children in the 1970s, the experimental use of deep sleep treatment and electro leucotomies on women in Nelson in the 1950s.

The 40-metre exhibition presents the often-brutal history of psychiatry in a series of panels and videos documenting over a century of human rights abuses around the world. Over 150 experts in medicine, law, psychiatry, education, etc were interviewed. The documentary comes with a warning however as no punches are pulled: it has an R-18 certificate.

CCHR was co-founded in 1969 by the Church of Scientology and Dr. Thomas Szasz, Professor of Psychiatry Emeritus from the State University of New York Health Science Center in Syracuse. As an international mental health watchdog they have successfully achieved hundreds of legislative protections against psychiatric abuse.

– 00 –

Contact information:

Steve Green

Executive Director

Citizens Commission on Human Rights

<!--[if !vml]-->


Thursday, 21 June 2012

An Irish mother's eulogy for her 22-year-old son - Sebastian victim of Shane Clancy

This is the full text of Nuala Creane's eulogy at the funeral of her son, Sebastian, in Dublin, Ireland yesterday. He was murdered by his girlfriend's ex-boyfriend ten days ago. He was buried in a wicker basket coffin. Her faith and forgiveness in the face of darkness is awe-inspiring. I just wanted to share it with the forum users to show how the light IS getting through in unexpected ways.

"Seb's body is back in a Moses basket. It’s a little bit bigger than the one he began life’s journey in, but it serves the same purpose: a place to rest.

We are faced with a grim reality today, burying my youngest son. Reality for me is the sum of all my experiences, my beliefs, my thoughts, which I project out into this world and with which I create my story.

In Ireland we have a great tradition of story-telling. Firstly, we tell stories to try to make sense of the human condition and secondly, when we share our story, we connect with one another. We come to know each other.

This morning, I am going to tell a story. In my story, my God is the God of Small Things. I see God’s presence in the little details.

My beloved J [her husband James] and I decided to have a second son – we didn’t know it was going to be a boy then of course – because we didn’t want D to be an only child. And I knew also that my expectations of Dylan, if he was on his own, would be too high.

Seb was eager to be born. He arrived three weeks early at 10 minutes to two in the afternoon.

Do you remember the old days when the clock faces in the haberdashery window all read ‘10 to 2’ because the face of the clock looked like it was smiling? If you’ve never seen it, look at Ledwidge’s window in Main Street. My God of Small Things was telling me this would be a happy child. And he was.

Seb has 45 first cousins. What a bountiful table to sup from throughout one’s childhood. Seb was also the youngest child in the Grove and he did his best to be as good as the rest of them.

At 2½, he could cycle his bicycle without stabilisers on which at every opportunity he would disappear around the corner, abandon the bike at the door of Pauline’s shop and stand with his curly head peering round the door, brown eyes trained on Pauline, waiting until she relented and gave him a sweet.

Still as a nipper, he was with me in Hickey’s one day when I was buying curtain hooks. As I queued to pay, I realised I needed another one. Showing the hook to Seb, I asked him to get me one from the shelf. When he brought me back the correct one, I stored the information away. He had a good visual memory. It would stand him in good stead.

Contrary to popular perception, academia for Seb was not easy, but fortunately, he met teachers in St Nicholas’s Montessori, St Cronan’s, St Gerard’s, Sallynoggin Senior College and Dún Laoghaire Institute, who challenged him, tested his mettle, supported him, praised him, so that he became a fine, young man.

The last gift Seb gave to J and I was during our summer back in June. One Sunday morning, Seb informed me that he fancied a swim down at the seafront. I didn’t pay much heed.

He asked J and J said ‘Yeah’, he’d walk down with him. I was asked a second time. I gave in. So around midday Seb threw the towel over his shoulder and the three of us traipsed down to the beach. We sat on the pebbles and watched him as he went in for his dip . . . As I watched Seb I thought the child in that fella is still alive. It’s a memory we treasure.

Maybe my God of Small Things is saying, let the child inside each of us come to the surface and play or, as a point of fact, that I was blessed with a sunny child. Or as a parent I know that the one gift each of us would want for our child, is that they are comfortable in their skin . . .

And now I ask what is my God of Little Things saying to me about this incomprehensible act which took place in our home on Sunday morning of August 16th? This tragic incident which caused mayhem in all our lives and robbed D of a younger brother he was proud of. As D himself said, Seb was like him but with swagger.

D, Seb, Jen and Laura faced a presence of demonic proportions that manifested through Shane Clancy. How do I, Seb and Dylan’s mother, even try to rationalise this one? We live on Earth in a world of contrasts – big, small, hard, soft, good, bad, dark and light, but one can’t paint a picture without at least two shades.

It is the dark which gives definition to the light. Darkness is just the lack of light.

Through my God of Little Things, I notice that both boys who died were 22. Both had the same initials. Both were entering their final year in college and looked set, even in these recessionary times, to have fruitful careers.

So many similarities, yet on the morning of August 16th, my God of Small Things said to me, one boy represented the light, the other the darkness, as they both played their parts in the unfolding of God’s divine plan.

And as a result we, my beloved J and I, and all of you, are faced with a choice: do we continue to live in darkness, seeing only fear, anger, bitterness, resentment; blaming, bemoaning our loss, always looking backwards, blaming, blaming, blaming, or are we ready to transmute this negativity?

We can rise to the challenge with unconditional love, knowing that we were born on to this earth to grow . . .

Our hearts are broken but maybe our hearts needed to be broken so that they could expand.

And now that we have our attention on our hearts, please bring to mind a happy moment in your lives – the happier the better. Now let that happy feeling fill your whole heart. Now bring your attention to Jen. She feels so responsible. She blames herself. Bathe her heart in that happiness. Let our happy thoughts wash those feelings out of her. Keep sending her your happiness. And then forgive yourselves.

I am so conscious of all you young people who came in contact with Seb. I know you’re bewildered and want to do something to make it right. The best way you can honour Seb’s life is to co-create the most enlightened lives you can. The light that shone in Seb shines in you also, in its own special way. Let it shine and be at peace.”

She also included an excerpt from the John Donne poem, No Man Is An Island:

No man is an island, entire of itself

every man is a piece of the continent, a part of the main

if a clod be washed away by the sea,

Europe is the less, as well as if a promontory were,

as well as if a manor of thy friends or of thine own were

any man's death diminishes me, because I am involved in mankind

and therefore never send to know for whom the bell tolls

it tolls for thee.

Monday, 18 June 2012

Shane Clancy victim's mother (Nuala Creane) seeks NEW inquest into his killer's death - FIDDAMAN blog ** Exclusive

Mother of murder victim in legal bid over new inquest into killer's death

The mother of a 22-year-old man stabbed to death in Co Wicklow almost three years ago, has begun legal proceedings to have a new inquest held into his killer's death.

Sebastian Creane was fatally stabbed at the family home in Bray, Co WicklowThe mother of a 22-year-old man stabbed to death in Co Wicklow almost three years ago has begun legal proceedings to have a new inquest held into his killer's death.

Nuala Creane, whose son Sebastian was stabbed to death by Shane Clancy at the Creane home in Bray, has been given permission by the High Court to challenge the Attorney General's refusal to direct a new inquest into Mr Clancy's death.

She is also challenging the failure of the Minister for Justice to make any decision on a complaint by her about the conduct of the Coroner for East Wicklow, Cathal Louth, who conducted the inquest into Mr Clancy's death.

Mr Clancy, 22, stabbed himself to death in the early hours of 16 August 2009 after stabbing his former girlfriend Jennifer Hannigan, her new boyfriend Sebastian Creane and Sebastian's brother, Dylan. Sebastian died from his injuries.

The inquest into Mr Creane's death returned a verdict of unlawful killing and found that he died of a knife wound to the heart.

The inquest into Mr Clancy's death returned an open verdict.

Mr Clancy's mother told the inquest she believed her son's actions were the result of the prescribed anti-depressants he had been taking.

The inquest heard he had "toxic to fatal" levels of the anti-depressant Cipramil in his system and evidence was given that he may have suffered an adverse reaction to the drug.

Lawyers for Mrs Creane told the High Court that the inquest into Mr Clancy's death was the only public judicial or quasi judicial forum in which the circumstances of the killing of Mr Creane would ever be fully considered, investigated or explored.

Mrs Creane says in advance of the inquest into Mr Clancy's death, the coroner reassured her and her husband about how he intended to conduct the inquest and to address expert evidence in respect of the purported relationship between the anti-depressant medication and the behaviour of Mr Clancy.

The Creanes claim the coroner failed to conduct the inquest in an open, fair or balanced manner and they say there was no reasonable or fair inquiry into the relevant circumstances surrounding the killing.

The High Court gave permission to Mrs Creane to proceed with her challenge and it will be before the court again next month.

Don't blame the medication for our Seb's killing, says his family; Creanes tell of their inquest pain

THE family of Sebastian Creane have revealed the torment they endured at attempts to portray his crazed killer as a victim.

Daily Mail (London)

May 7, 2010

His grieving relatives spoke out yesterday after an inquest ruled that 22-year-old Sebastian had been 'unlawfully killed' by his girlfriend's jealous ex-boyfriend, Shane Clancy, who also stabbed two others before killing himself.

At Clancy's own inquest, a month ago, the Creanes listened to his mother, Leonie Fennell, blame her son's frenzied behaviour on prescribed anti-depressants. She said: 'I don't need a medical expert to tell me Shane wasn't capable of hurting anybody or himself if he wasn't on …

mental illness: only 25% of people in need get help - we need cabinet minister not CCHR FIDDAMAN

Scandal of mental illness: only 25% of people in need get helpReport urges appointment of special cabinet minister and says 'millions wasted' through lack of proper treatment

Email Sarah Boseley, health editor

The Guardian, Monday 18 June 2012

Of the 6.1 million people with treatable anxiety or depression in England, only 131,000 entered talking therapy in the last quarter of 2011. Photograph: PA

The "scandalous" scale of the NHS's neglect of mental illness has been described in a report which suggests only a quarter of those who need treatment are getting it.

The report claims that millions of pounds are being wasted by not addressing the real cause of many people's health problems. Nearly half of all the ill-health suffered by people of working age has a psychological root and is profoundly disabling, says the report from a team of economists, psychologists, doctors and NHS managers, published by the London School of Economics.

Talking therapies such as cognitive behaviour therapy relieves anxiety and depression in 40% of those treated, says the Mental Heath Policy Group led by Lord Layard. But despite government funding to train more therapists, availability is patchy with some NHS commissioners not spending the money as intended, and services for children being cut in some areas. "It is a real scandal that we have 6 million people with depression or crippling anxiety conditions and 700,000 children with problem behaviours, anxiety or depression," says the report. "Yet three quarters of each group get no treatment."

Layard added: "Mental health is so central to the health of individuals and of society that it needs its own cabinet minister … The under-treatment of people suffering from mental illnesses is the most glaring case of health inequality in the NHS … Despite the existence of cost-effective treatments it receives only 13% of NHS expenditure. If local NHS commissioners want to improve their budgets, they should all be expanding their provision of psychological therapy."

A third of families have a member suffering a mental illness, the authors found. The report says mental health problems account for nearly half of absenteeism at work and a similar proportion of people on incapacity benefits.

In 2008, Layard and others won the argument that treating anxiety and depression saved the NHS money. A programme called Improving Access to Psychological Therapy (IAPT) was set up to train thousands more therapists.

Official figures, however, show that too few people are getting treatment across the country. There were 6.1 million with treatable anxiety or depression in England but only 131,000, or 2.1%, entered talking therapy in the last quarter of 2011.

There are stark differences between primary care trusts. Walsall did best, with 6.4% of depressed and anxious people in talking therapy, followed by Swindon with 5.8% and Northumberland with 5.5%.

But Hillingdon, west London had only 0.1% in treatment – 17 out of 29,000. Barnet and Enfield, both in north London, had 0.3% and 0.4% respectively.

Layard said commissioners were wrong "if they think 'why don't we cut a bit of that [talking therapies]' when they are spending money on infinitely lower priority conditions. Depression is 50% more disabling than conditions like angina, arthritis, asthma or diabetes." Even including those on medication, treatment only reaches a quarter of those in need.

Commissioners needed to understand that treating people with mental illness saves money, the report says. Layard pointed to a survey at two London hospitals which found that half the patients sent for an appointment with a consultant had physically inexplicable symptoms, such as chest and head pains for which there was no organic explanation. "These are people with somatic symptoms as a result of mental stress," he said.

In the long term he said he would like to see psychologists and therapists working alongside physical medicine doctors in the acute sector, to help determine the real cause of people's apparently inexplicable symptoms.

Dr Andrew McCulloch, chief executive of the Mental Health Foundation, said the report showed mental health remained a poor relation to physical health for the NHS. "The government has rightly committed to a parity of esteem between physical health and mental health in the health and social care bill, and surely they must now deliver on what they have promised."

Dr Clare Gerada, the chair of the Royal College of GPs, applauded the efforts of Layard and his colleagues to increase the availability of talking therapies.

"We live in a stressful society and the number of patients with mental health problems presenting to GPs is on an upward spiral," she said. "GPs face tremendous challenges in caring for patients with mental health problems in primary care and we welcome any development which will help us improve their care."

The care services minister, Paul Burstow, said: "Mental ill-health costs £105bn per year and I have always been clear that it should be treated as seriously as physical health problems … the coalition government is investing £400m to make sure talking therapies are available to people of all ages who need them. This investment is already delivering remarkable results."

'Only 1 in 4' UK mental illness sufferers treated - flies in the face of Scientology FIDDAMAN claims

'Only 1 in 4' UK mental illness sufferers treated

(AFP) – 5 hours ago

LONDON — Three out of four people with mental illness in the UK are receiving no treatment, experts have said in a new report.

The report, published by the London School of Economics (LSE), says the lack of treatment for people suffering from mental health problems is the most "glaring case of health inequality" in Britain.

Among people under the age of 65, mental illness now accounts for nearly half of all ill health suffered by people in Britain and is generally more debilitating than most chronic physical diseases, the report published on Monday concluded.

Effective psychological therapies exist but are not widely available and only a quarter of sufferers are receiving treatment, the report by the LSE's Mental Health Policy Group found.

It is thought that around two-fifths of patients suffering from anxiety or depression can recover if they are treated by methods such as cognitive behavioural therapy.

The authors -- a distinguished team of economists, psychologists, doctors and NHS managers -- say that if such treatments were more widely available it would cost the NHS little or nothing overall because it would produce savings in other areas of healthcare.

They estimate that mental health problems which manifest themselves in physical symptoms cost the NHS at least ten billion pounds.

"Despite the existence of cost-effective treatments it (mental illness) receives only 13% of NHS expenditure," they wrote.

LSE Professor Lord Richard Layard, who convened the report's authors, argues that mental health is so prevalent in society that it deserves its own cabinet minister.

"If local NHS commissioners want to improve their budgets, they should all be expanding their provision of psychological therapy," Layard said.

"It will save them so much on their physical healthcare budgets that the net cost will be little or nothing.

"Mental health is so central to the health of individuals and of society that it needs its own cabinet minister."

The British Medical Association (BMA), the professional association and trade union for doctors, welcomed the reports' findings.

"The BMA is concerned about the poor physical health and early death of many with serious mental health problems, and views this as a major inequity that must be addressed," it said in comments quoted on the LSE's website.

"We will be undertaking more work on this area in our next session and today's report is an excellent starting point for that work."

SEROXAT lawyer Hugh James blown out of the water yet again as - PIP implant material non toxic

The final report into the PIP breast implant scandal has concluded that the gel material has does not cause a long-term threat to human health.  

It says the implants, which were made with unauthorised silicone filler are not toxic nor carcinogenic.

The review, led by Prof Sir Bruce Keogh, the NHS medical director, said they do have double the rupture rate of other implants.

Around 47,000 women in the UK have had the implants fitted.

Around 95% were fitted privately. A minority of operations were carried out on the NHS, mostly for breast reconstruction following cancer.

In January Prof Keogh's team concluded there was insufficient evidence to recommend the routine removal of PIP implants. But it recognised the concern that the issue was causing.

It found there was no link between PIP implants and cancer, and the evidence on increased rupture rates was inconclusive.

Last month, a separate review led by Health Minister Lord Howe examined the role of the Department of Health and the UK regulator the MHRA.

Rupture Rate

The report says the PIP implants have around double the rupture rate of other implants.

After five years, the rate is between 6% and 12%.

After 10 years, the rate is between 15% and 30%

Other brands have a failure rate between 10% and 14% after a decade.

It said serious lessons must be learned and questioned how well women with these implants were informed about the risks.

The president of the British Association of Aesthetic Plastic Surgeons, Fazel Fatah, said: "Despite rigorous testing showing no long-term danger to human health from the individual chemicals in the gel, the fact remains that PIPs are significantly more likely to rupture and leak and, therefore, cause physical reactions in an unacceptable proportion of the patients.

"We agree with the report findings that anxiety itself is a form of health risk and thus it is entirely reasonable for women to have the right to opt for removal - regardless of whether there has been rupture."

The advice for patients has not changed.

Throughout the UK any women who had PIP implants fitted on the NHS can get them removed and replaced free of charge.

In Wales the NHS will also replace those of private patients. In England and Scotland the NHS will remove implants of private patients but not replace them.

NHS in England was guilty of injustice in its treatment of people with mental illness - but FIDDAMAN goes to N Zealand?

NHS managers in England have been accused of "shocking discrimination" in commissioning mental health services.

The Mental Health Policy Group from the London School of Economics said three-quarters of people with depression or anxiety got no treatment.

The committee of senior academics and medical professionals described this as a "real scandal".

Care Services Minister Paul Burstow said mental health should be treated as seriously as physical health issues.

The committee is headed by economist Professor Lord Richard Layard and includes some of the country's most eminent mental health experts.

Official guidance

It said the NHS in England was guilty of injustice in its treatment of people with mental illness.

The group's report found that among those aged under 65, nearly half of all ill-health was mental illness.

It said six million people had depression or anxiety conditions and yet three-quarters got no treatment

This was often because NHS managers failed to commission properly the mental health services recommended in official guidance, the experts added.

They said £400m earmarked by the government for psychological therapy was not always used for its intended purpose because there was no obligation on managers to do so.

The committee concluded that mental health services should be expanded, but if anything it was being cut.

'Little cost'

Lord Layard said: "If local NHS commissioners want to improve their budgets, they should all be expanding their provision of psychological therapy.

"It will save them so much on their physical healthcare budgets that the net cost will be little or nothing.

"Mental health is so central to the health of individuals and of society that it needs its own cabinet minister."

Mr Burstow said investment in mental health services was "already delivering remarkable results".

"Mental ill-health costs £105bn per year and I have always been clear that it should be treated as seriously as physical health problems," he said.

"We will shortly publish our plans to make sure the NHS, councils, voluntary organisations and others can play their part in improving the nation's mental health.

"The coalition government is investing £400m to make sure talking therapies are available to people of all ages who need them."

Sunday, 17 June 2012

Hospice provider use therapy dogs called PAXIL - Bob FIDDAMAN sure to approve

Patty Kaplan, left, and Barbara Fosnaugh talk about Paxil, a registered therapy dog.

Paxil, a black and white Large Munsterlander Pointer, sat next to Barbara Fosnaugh as the 87-year-old patted his head.

Usually, the “70-pound lapdog,” as his owner describes him, will lay across her feet or snuggle up to her, when he visits every other week, but the wheelchair she was in Friday made that harder.

“He just makes my day,” she said. “I wish he could come more often.”

Paxil is a registered therapy dog that has been working with patients of Iowa Health Hospice. Now, officials there are trying to recruit more dogs for the metro-area’s first animal assisted therapy program focusing on hospices.

Paxil’s owner, Patty Kaplan, the president of Paws for Therapy Inc. and the consultant helping start the program, as well as hospice officials emphasized the benefits for patients dogs can provide.

Various studies have shown interacting with therapy animals can help decrease patients’ blood pressure, heart rate and stress hormones and help them reduce the amount of medication they must take.

“This is evidence based,” Kaplan said. “But really, it’s a moment of the day where they can just wrap their arms around the dog and take their minds off of things.”

Leanne Burrack, the director of hospice care for Iowa Health Hospice, said adding the dogs to the organization’s list of other forms of therapy will help provide comfort to patients, as well as their families.

“They can provide comfort, joy and delight that sometimes humans can’t,” she said.

The organization is looking for dogs and handlers to expand the program. Neither dog nor human needs any experience with therapy work, but dogs must be well-behaved and meet some other requirements.

The selection and training process will take much of the summer and officials hope to launch the program by September.

Kaplan and Paxil will be at the Des Moines Downtown Farmer’s Market to answer any questions people may have and distribute applications.

More information on how to volunteer is also available at or by calling (515) 557-3287

Maria Bradshaw Takes In Stalking Bully Bob Fiddaman and Moves Him to New Zealand

Saturday, 16 June 2012

Europe drops GlaxoSmithKline Paroxetine (Seroxat) investigation, but don't expect FIDDAMAN to tell you

The day after announcing it had closed its investigation into AstraZeneca, the Commission confirmed on 2 March that it had administratively closed an investigation involving GlaxoSmithKline and Synthon. It has been reported that the case was closed following the withdrawal of a complaint and that the investigation related to the antidepressant drug Paroxetine. GlaxoSmithKline previously confirmed in a company filing that the Commission had carried out an inspection in 2005 at its premises following allegations about an abuse of dominance relating to Seroxat, the trade name for Paroxetine.

However, GlaxoSmithKline also continues to face scrutiny from a national competition authority relating to generics. In August 2011, the OFT opened a formal investigation into GlaxoSmithKline and Generics UK, looking at whether litigation settlements and payments to potential generic suppliers in relation to paroxetine restricted competition. In a company statement, GlaxoSmithKline has confirmed that the subject matter of the OFT’s investigation is the same as the recently closed EC case. It remains to be seen whether the OFT, unlike the EC, will take further action relating to its investigation of brand-generic agreements.

Wednesday, 13 June 2012

Zoloft Sertraline - Calif. jury finds ex-police officer guilty of rape - keep up to-date with FIDDAMAN blog

Calif. jury finds ex-police officer guilty of rape

(AP) – 1 hour ago

RANCHO CUCAMONGA, Calif. (AP) — A former police detective who blamed the antidepressant Zoloft for his behavior was found guilty Wednesday of kidnapping and raping a waitress at gunpoint in a brutal attack.

A San Bernardino County jury will now have to determine whether Anthony Nicholas Orban was sane at the time of the attack.

Orban's attorney argued during trial that his client suffered a psychotic break because he was taking Zoloft and was effectively unconscious when he kidnapped the woman in the Ontario Mills mall parking lot in San Bernardino County.

Prosecutors say the off-duty officer used his service weapon to force the woman to drive to a self-storage lot, where he sexually assaulted her and shoved a gun in her mouth on April 3, 2010. The woman escaped when Orban was distracted by an incoming cellphone call, prosecutors said.

Deputy District Attorney Debbie Ploghaus declined to comment on the verdict, noting the sanity phase of the trial begins Tuesday.

Orban, a 32-year-old who served in the Marines in Iraq, had pleaded not guilty and not guilty by reason of insanity to eight counts, including kidnap and rape. Defense attorney James Blatt said the crux of the case is not the elements of the crime but whether his client was aware of what he was doing.

Blatt said his client had been taking Zoloft for six months, but had gone off the medication and recently restarted it. Orban does not recall the incident, Blatt said.

"This is something that appears to be totally out of character for him," Blatt said.

If Orban is found to have been sane, he could face a life sentence, Blatt said. If he is found to have been insane, he would be sent to a mental institution for treatment.

The woman, who was 25 at the time of the attack, testified that Orban sexually assaulted her, punched her, choked her, stuck a gun in her mouth and took cellphone photos of her. She told jurors that the attacker did not appear disoriented or unconscious, the San Bernardino Sun reported.

But she also testified that at the end of the attack, he looked at her and asked: "Who are you? How did I get here? Whose car is this?"

A friend of Orban's, Jeff Jelinek, testified against him. Prosecutors said the former prison guard and Orban had been drinking at the mall and Jelinek was standing next to Orban during the kidnapping and picked him up after the attack.

In a plea deal with prosecutors, Jelinek pleaded no contest last year to being an accessory, false imprisonment and assault.

Copyright © 2012 The Associated Press. All rights reserved

2001 paroxetine suit - FIDDAMAN accused of being a scientologist

There has been a recent class action lawsuit in the States against the

makers of a drug called Paroxetine.
I have been on this drug for the past two and a half years and am now
hooked. Any phased withdrawal has me going through all the symptomatic
problems that this dug professes WILL NOT occur.

What is a class action Lawsuit?
How do I sue the Makers of this drug
Many Thanks


Well, I was on it for a similar length of time and had no problem coming
off it. You're not some Scientology freak trying anything possible to
have a pop at drug companies, are you?

> What is a class action Lawsuit?
> How do I sue the Makers of this drug

See a solicitor and give him a lot of money, with as many others as you
can find.

Or you could piss off instead.

Wolverhampton (15 miles from Birmingham) UK

Tuesday, 12 June 2012

Diagnosing schizophrenia can often take a while because there is no single test - NHS on FIDDAMAN blog

Making a diagnosis

Diagnosing schizophrenia can often take a while because there is no single test, and the symptoms can be similar to those for some other brain disorders. A person may not want to say they feel unwell, and symptoms include paranoia and a lack of self-awareness, making diagnosis difficult.

The WLMHT care team will listen to what a person and their carers say, evaluate a range of symptoms, and make a diagnosis based on all the evidence gathered over a period of time.

Early warning signs

The WLMHT care team helps a person identify the early warning signs that a schizophrenic episode is coming. This is known as their relapse signature. Knowing a person’s relapse signature means that help can be arranged early and before an episode escalates.

Early warning signs can include:

•Sudden mood changes

•Flattening of emotions, desires and interests

•Reduced ability to cope, especially with stress and relationships

•Odd responses to people and events

Sudden onset

Sometimes, as a result of extreme stress, the onset of schizophrenia can seem quite sudden, with a person developing severe symptoms such as seeing and hearing imaginary things within a few weeks.

It may seem that a person has had a sudden breakdown, but it is not unusual for people to say they had been coping with symptoms for a long time. It may not be until other life stresses caused them to experience a breakdown that the full extent of their schizophrenia is revealed.

Monday, 11 June 2012

FIDDAMAN banned from E-BAY - seems GSK GlaxoSmithKline can't get enough of Bobby's scams

Referring URL: (No referring link)

Host Name: Browser: Chrome 19.0

IP Address: — GSK Operating System: WinXP

Location: United Kingdom Resolution: 1280x1024

Returning Visits:  Javascript: Enabled

Visit Length: Multiple visits spread over more than one day ISP: Glaxosmithkline

Navigation PathDate Time WebPage

(No referring link)

11 Jun 10:00:55​-life​-spent.html?spref​=tw

Saturday, 9 June 2012

Blast from the past - Bob Fiddaman a life spent as a professional victim

fiddaman64 View profile

More options 4 Apr 2004, 07:50

Newsgroups: uk.people.consumers.ebayFrom: 'fiddaman64' Date: Sun, 04 Apr 2004 07:50:01 GMTLocal: Sun 4 Apr 2004 07:50Subject: Account suspended????Reply to author Forward Print Individual message Show original Remove Report this message Find messages by this author

As I understand, selling copies of bootlegged concerts is illegal on Ebay. I
have recently been suspended despite carrying a disclaimer that Ebay had
nothing to do with my sales.

I listed a load of bootlegs and told the viewer that he/she was actually
bidding on the envelope as it was illegal to 'sell' bootlegs on Ebay. The
CDR would be a 'FREE' gift.

Question. Technically Ebay have suspended my account for selling envelopes,
is there a body I can complain to?


WALES - antidepressants out of control in Dr David Healy's back yard - so much for FIDDAMAN / CCHR kicking ass campaign

Sadly, with a monotonous inevitability, this story plays out in April every year following the publication of the annual Prescription Cost Analysis data.

top search - Latest news on Bob Fiddaman in New Zearland

Wednesday, 6 June 2012

major anti-Scientology conference will be held in Dublin on June 30th - check this out Leonie Fennell, for your own sake

A major anti-Scientology conference will be held in Dublin on June 30th featuring Jamie De Wolfe the great grandson of Ron Hubbard the movement’s founder.

Writing in former Scientology memeber and conference organizer Pete Griffiths stated that the conference called “Dublin Offlines” is “organised by ex-members of the Scientology organisation, independent Scientologists, critics of the Scientology organisation and family members of those who have been affected by Scientology.

He says he has been labelled a “suppressive person” by the organization

Griffiths stated that since leaving the organization his brother has disowned him and he realised that he had suffered a form of brainwashing.

“You can’t voice your doubts, you just don’t. You are with us or you are not – that is it. If you do voice any doubts, you are routed to Ethics (the internal police force) and basically told to shut up. If you are complaining or you have doubts you are told that you are a Suppressive Person (SP) and they don’t like suppressive people. The religion is full of little traps and pitfalls like that.

“After we left staff at the organisation – I got a golden rod – which is a piece of paper that declares me as a Suppressive Person for leaving the organisation. It is Scientology policy that these orders are printed on a piece of coloured paper. Only ethics orders are printed on paper this colour.”

Griffiths stated that he had joined the organization back in 1987 when his brother bought a book called Dianetics, the bible of the movement.

“ But it is never as simple as buying a book from them, he wrote in” If you buy a book you don’t just get a receipt – you have to fill out an invoice with your name, address and phone number and then they will give you a call you a few days later to see how you are getting on with it.”

His wife was dismissed from the organization “as they had discovered that she had previously been a psychiatric nurse – they didn’t like that, as they are against psychiatry and psychology and they believe they have all the answers to problems of the mind.“

Griffiths warned young people against joining the organization “I would just say to anyone that is contemplating getting involved in Scientology – just don’t do it. I know it is hard out there for people at the moment and that people are looking for answers but Scientology is just not the way to go – believe me.”

Here's a clip of Jamie DeWolfe discussing Scientology:

Read more:

FIDDAMAN names GIBBONS as GSK expert witness in seroxat litigation ...seems they got history

Fiddaman is not very keen on statisticians like it seems, so expect lots of yelling and bawling from Bob on Gibbons latest work on antidepressant black box - link

here is some other statistics
Bob can't cope with -

Doubt Cast on Suicide Risk of Antidepressants - Gibbons and colleagues - world turns upside down for FIDDAMAN

MONDAY, June 4, 2012 (MedPage Today) — Short-term risks of suicidality associated with antidepressant drugs — highlighted in an FDA-mandated boxed warning — may have been exaggerated, said researchers who reviewed more than 40 controlled trials of two popular products.

In fact, compared with placebo, suicidal ideation was diminished with fluoxetine (Prozac) and venlafaxine (Effexor) in adults, including geriatric patients, and was not increased in children and teens in the trials, according to Robert D. Gibbons, PhD, of the University of Chicago, and colleagues.

The researchers found that suicide risk closely followed the severity of depression in adult trial participants — as depression eased, so did the likelihood of suicidal thoughts.

By the same token, Gibbons and colleagues reported in the June issue of Archives of General Psychiatry, suicide risk remained relatively high in patients who did not respond to the antidepressant treatment.

"For all adult trials, depression severity mediated the effect of antidepressant medication on suicide risk. Mediation accounted for approximately 80 percent of the overall treatment effect in adults, but less (57 percent) for geriatric patients," they wrote.

"Our findings emphasize the need to successfully treat episodes of major depressive disorder to lower the suicide risk."

Yet, in children and teens, the study also yielded a perplexing result — antidepressant treatment clearly reduced depression symptoms but with no corresponding decline in suicidality risk.

"Perhaps other psychopathology plays a more important role in suicidal behavior and ideation such as aggressive impulsive traits in youths," Gibbons and colleagues speculated.

The boxed warnings on antidepressants, indicating a heightened suicidality risk in children and teens, were first required in 2004 and were extended 2 years later to include adults 18 to 25.

They were based on adverse event data in industry-sponsored clinical trials, Gibbons and colleagues explained. An FDA meta-analysis in younger patients found an odds ratio of 1.78 for suicidality in children and adolescents receiving selective serotonin or serotonin-norepinephrine reuptake inhibitors (SSRIs/SSNRIs) relative to placebo.

A similar analysis of adult patient data found a nearly identical increase in suicidality in those ages 18 to 24 but a reduced risk in older adults including geriatric patients.

But the FDA analyses and subsequent studies did not take "the mediating role of depressive symptoms" into account, Gibbons and colleagues indicated. Moreover, the FDA examined only data connected to study endpoints, not the full longitudinal data available from the sponsors.

For the new study, Gibbons and colleagues obtained complete longitudinal data for 20 placebo-controlled trials of fluoxetine (all but one supplied by Eli Lilly) and 21 involving venlafaxine, provided by its manufacturer, Pfizer's Wyeth unit. Some of these were unpublished.

Suicide risk was evaluated in these trials with items in the Children's Depression Rating Scale-Revised and the Hamilton Depression Rating Scale, plus adverse event reports of actual suicidal behavior (attempted and successful). Such reports were rare — there were only two completed suicides and 20 attempts among participants in the 41 trials.

The data covered a total of 9,185 patients and 53,260 patient-weeks of observation, divided nearly equally between the two drugs. For venlafaxine, about half the patients had taken an immediate-release form of the drug and the others had taken an extended-release version.

Four of the fluoxetine trials were conducted in youths 17 and younger; four were in geriatric patients; and 12 were in nongeriatric adults. All the venlafaxine trials involved nongeriatric adults.

For fluoxetine, the meta-analysis indicated a lower risk of suicidality with the drug relative to placebo during the first 5 weeks of therapy, followed by an increased risk in weeks 6-8. Beyond week 8, the risk was again lower, but Gibbons and colleagues noted that the longer-term data were "sparse."

In adults and geriatric patients treated with fluoxetine, and in those receiving venlafaxine, treatment clearly reduced suicidality risk relative to placebo.

Gibbons and colleagues used a measure called "marginal maximum likelihood estimate" (MMLE) to quantify the effect of treatment on suicidality over time.

"The beneficial effect of treatment on the probability of suicide risk is apparent approximately 2 weeks following treatment initiation," the researchers wrote.

Still, the bottom line for Gibbons and colleagues was that the lack of association with fluoxetine treatment indicates that the drug did not heighten suicidality risk.

The researchers noted that their analysis in children and teens only involved fluoxetine, leaving the generalizability to other antidepressants uncertain.

Another limitation to the study included the small number of suicide attempts. "Suicidal ideation rates and the ratios to suicides and suicide attempts are higher in youths compared with adults, making ideation a potentially weaker indicator of risk of behavior in youths," Gibbons and colleagues noted.

The reliance on depression rating-scale items and adverse event reports for the evaluation of suicidality was also a potential limitation, the researchers indicated.

Last Updated: 06/05/2012

Tuesday, 5 June 2012

Hot topic - bob fiddaman leaked details to news agency for profit

Telecom Internet Registry ( [Label IP Address]  returning visit

New Plymouth, Taranaki, New Zealand — bob fiddaman leaked details to news agency for profit. #1

5 Jun 11:59:50​-midlands.html

5 Jun 12:01:18​-to-news.html (Exit Link)

Sunday, 3 June 2012

Fatal toxicity: rate ratios and relative toxicity indices for individual antidepressants - FIDDAMAN sleep aid most dangerous of all

FIDDAMAN used the following night cap - see link

the evidence is clear that Dosulepin is the most fatally toxic of all !!

Antidepressant death by suicide - per individual brand England & Wales - facts FIDDAMAN not idle speculation


To assess the relative toxicity of specific tricyclic antidepressants (TCAs), a serotonin and noradrenaline reuptake inhibitor (SNRI), a noradrenergic and specific serotonergic antidepressant (NaSSA), and selective serotonin reuptake inhibitors (SSRIs).
Observational study of prescriptions (UK), poisoning deaths involving single antidepressants receiving coroners’ verdicts of suicide or undetermined intent (England and Wales) and non-fatal self-poisoning episodes presenting to six general hospitals (in Oxford, Manchester and Derby) between 2000 and 2006. Calculation of fatal toxicity index based on ratio of rates of deaths to prescriptions, and case fatality based on ratio of rates of deaths to non-fatal self-poisonings.


Toxicity of antidepressants: rates of suicide relative to prescribing and non-fatal overdose

Keith Hawton, DSc, Helen Bergen, PhD and Sue Simkin, BA
Jayne Cooper, PhD
Keith Waters, RMN
David Gunnell, PhD
Navneet Kapur, MD

Friday, 1 June 2012

GSK - Andrew Witty has only one inbound link ....yes it's FIDDAMAN

Outbound links information for

If a site has a lot of outbound links (these are links from the site to third-party sites) it is bad for the site reputation, and also it can be a signal that the site is exchanging link ads. These practices are a good argument for search engines to penalize the sites for manipulating the results.

We found 94 outbound links to, but we show only 30 of them (0 with nofollow relation).

Our opinion is that has too many outer links. Our advice to webmasters is to decrease number of this urls. Website Link Anchor A Paxil Withdrawal/Addiction Story ABC Primetime : Paxil ( Seroxat ) Addiction Advair and Serevent : GSK Drugs : Warnings for Asthma Drugs Sought Aids Activists Take Over Glaxo Investor Relations Office Banned Depression Tablets Are Still Being Prescribed To Thousands (Seroxat) Big Pharma FDA Blog Birth Defects Caused By Seroxat( Paxil) blog Consumer Protest GlaxoSmithKline Antidepressant Paxil Consumers International : GSK : Unethical Drug Promotion Coroner calls for Seroxat drug to be withdrawn (Paxil/Aropax/Paroxetine) Doctoring the Evidence: GlaxoSmithKline Pushes Depression Drug Epilepsy Sufferers – Lamictal Warning Evelyn Pringle (GSK – Avandia / Seroxat Articles) FDA Issues Safety Alert About Avandia ( Risk Of Heart Attacks) FDA tells Glaxo to pull misleading Flonase ads Furious Seasons ( Blog pushing for transparency in the psych drug industry) Ghost Writers on the Sly (GSK-Paxil-Seroxat-Scandal) Glaxo = Unethical ? Glaxo Accused Of Persistant Fraud By New York Attorney General Glaxo to pay $3.4B to settle biggest tax dispute in history (USA Today) Glaxo’s Guinea Pigs GlaxoSmithKline : False Advertising And Unethical Marketing GlaxoSmithKline CEO: “We had to absorb a number of hits” GlaxoSmithKline Fined for False Advertising of Soft Drink: Discovered by High School Students GlaxoSmithKline’s Deadly Cover Up GlaxoSmitKline ( Seroxat Secrets Articles) GSK “Myodil” – The 7 million back Pain GSK ‘ “Just Plain Murder” : Depression Dialogues : Michael Corry GSK ,In Bed With Saddam? (Pharmalot) GSK – Blog Addresses Corporate Manslaughter

Inbound links information for

More links to the site, mean better reputation of the site in search engines, and also if the links are from quality web sites, it makes the site more trustworthy.

We found 1 inbound links to Website Traffic Rank Link Anchor Date Checked 1M+ Andrew Witty GSK CEO (GlaxoSmithKline) : Pharmaceutical 29 Mar 2012